On 25 Dec., 2025, vitamin prices remained stable. After a significant increase in the prices of some vitamins in November due to factory shutdowns for maintenance and rising raw material costs, prices did not rise or fall further due to the demand constraints from downstream manufacturers, maintaining the status of November.
On the policy front, on 10 Dec., 2025, SyncoZymes's Nicotinamide Mononucleotide (NMN) raw material was approved by the Therapeutic Goods Administration (TGA) of Australia. On 11 Dec., 2025, the European Union announced approval for the use of 25-hydroxycholecalciferol preparations as feed additives.
In terms of market dynamics, on 27 Nov., 2025, Adisseo released the latest vitamin nutrition guide. On 9 Dec., 2025, Church & Dwight sold its brand VMS to Piping Rock. On 15 Dec., 2025, Garden Biopharma announced an increase in funding for vitamin B6 and biotin projects.
This month saw a new construction project: On 8 Dec., 2025, Boyuan Pharmaceutical invested USD16.96 million (RMB120 million) to build an annual production project of 100 million vitamin D tablets.
The exchange rate of US dollars/RMB in this report is 1 US dollar = 7.0759 RMB, sourced from the People's Bank of China on 1 Dec. 2025. Unless otherwise stated, all prices mentioned in this report include value-added tax.
Please purchase to view
Add to cart
